Hallé L, Jallu V, Mulen-Imandy G, Bigot A, M'bayo K, Anani L Y, Kaplan C
Institut National de la Transfusion Sanguine, Paris, France.
Transfusion. 2008 Jul;48(7):1415-22. doi: 10.1111/j.1537-2995.2008.01699.x. Epub 2008 Apr 18.
Previous studies of platelet allele frequencies in Sub-Saharan African populations enabled us to identify discrepancies in HPA-3 typing, suggesting the presence of new mutations and of a greater polymorphism than so far described in other populations.
To analyze these discrepancies and to assess the factors leading to potential alloimmunization in these populations.
Maternal samples from a Beninese woman following in utero death and panels of blood donors from Benin, Cameroon, Congo, and Pygmies from Central Africa.
Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), PCR-sequence specific primers (PCR-SSP) and sequencing techniques.
Three new mutations were found on GPIIb gene: exon 26 a) 2614C>A situated between HPA-3 and HPA-9w, b) 2645C>T downstream of HPA-3, c) intron 26 IVS26+89G>A. These mutations may lead to discrepant DNA typing results, due either to a localization in the complementary sequence recognized by the primer or to the appearance of a new enzyme restriction site. Furthermore, a bilateral linkage << deletion (Delta9 bp) intron 21 and the HPA-3b allele (exon 26) >> found in Caucasian, Asian, and Oceanian populations is not found in African populations, suggesting that its appearance was prior to HPA-3.
Three new mutations have been identified, two of them potentially immunogenic through their position. Furthermore, the polymorphism found on intron 26, localized in the complementary sequence of the PCR primer, may lead to a false typing assignation. It is therefore important to diversify techniques, both genomic (PCR-RFLP and PCR-SSP), and proteomic monoclonal antibody-specific immobilization of platelets antigen (MAIPA) to ensure accurate HPA antigenic system typing.
先前对撒哈拉以南非洲人群血小板等位基因频率的研究使我们能够识别HPA-3分型中的差异,这表明存在新的突变以及比迄今在其他人群中描述的更大的多态性。
分析这些差异,并评估导致这些人群中潜在同种免疫的因素。
一名贝宁妇女子宫内胎儿死亡后的母体样本,以及来自贝宁、喀麦隆、刚果的献血者样本和中非俾格米人样本。
使用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)、PCR序列特异性引物(PCR-SSP)和测序技术进行基因分型。
在GPIIb基因上发现了三个新突变:外显子26 a)位于HPA-3和HPA-9w之间的2614C>A,b)HPA-3下游的2645C>T,c)内含子26 IVS26+89G>A。这些突变可能导致DNA分型结果出现差异,这要么是由于位于引物识别的互补序列中,要么是由于出现了新的酶切位点。此外,在高加索人、亚洲人和大洋洲人群中发现的双侧连锁<<21号内含子缺失(Delta9 bp)和HPA-3b等位基因(外显子26)>>在非洲人群中未发现,这表明其出现早于HPA-3。
已鉴定出三个新突变,其中两个因其位置可能具有免疫原性。此外,在PCR引物互补序列中发现的内含子26上的多态性可能导致错误的分型判定。因此,重要的是使基因组技术(PCR-RFLP和PCR-SSP)和蛋白质组学血小板抗原特异性单克隆抗体固定化(MAIPA)技术多样化,以确保准确的HPA抗原系统分型。